文献速递产科母胎医学

俄亥俄州孕产妇安全质量改进项目:新冠疫情期间实施的全州围产期高血压质量改进项目初步结果

The Ohio Maternal Safety Quality Improvement Project: initial results of a statewide perinatal hypertension quality improvement initiative implemented during the COVID-19 pandemic.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-03-30

该质量改进项目于2020年7月至2021年9月纳入俄亥俄州29家1至4级产科医院,收集4948例重度高血压事件(4678例独特患者)数据。主要过程指标(60分钟内接受适当急性降压治疗)从基线56.5%升至67.4%(提高19.3%,P<.001),次要过程指标显著提高26.1%至166.8%(均P<.001),改善在不同种族和医院级别间无差异,且在新冠疫情期间持续。

要点

  • 主要过程指标:重度高血压60分钟内适当治疗比例从56.5%升至67.4%(提高19.3%,P<.001)。
  • 次要过程指标显著提高26.1%至166.8%(均P<.001)。
  • 改善在不同种族和医院级别间无差异,且在新冠疫情期间达到并维持。

核心结论

  • 该项目在识别和治疗妊娠期及产后重度高血压方面实现了有意义的过程指标改善。
  • 改善在所有医院级别中均实现,且未观察到种族或族裔差异。
  • 研究结果表明,在全球大流行背景下,具有适当支持和资源的稳健综合质量改进计划可取得有意义的进步。

研究设计与样本

  • 俄亥俄州孕产妇安全质量改进项目,纳入1至4级产科医院,提供多模式质量改进支持。
  • 参与医院每月提交新发持续性重度高血压病例的患者级数据。
  • 2020年7月至2021年9月共29家医院参与,收集4948例高血压事件,代表4678例独特患者。
  • 主要过程指标为60分钟内接受适当急性降压治疗的比例;次要过程指标包括出院后72小时内(带药出院)或10天内(不带药出院)随访预约、出院时血压计、紧急孕产妇警告症状教育。
  • 数据每两周绘制,采用统计过程控制方法识别特殊原因变异,并按种族或族裔、保险状态和孕产妇护理级别分层。

主要发现

  • 主要过程指标(及时适当治疗)总体提高19.3%(从基线56.5%升至67.4%;P<.001)。
  • 次要过程指标显著提高,范围为26.1%至166.8%(均P<.001)。
  • 非西班牙裔黑人和白人孕产妇在重度高血压治疗方面均显示转变和持续改善,研究期间未因种族而异。
  • 过程指标改善在新冠疫情期间高峰期间达到并维持。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertensive disorders of pregnancy are a leading cause of severe maternal morbidity and mortality, and studies have shown that more than 60% of cases are preventable. As part of a statewide quality Maternal Safety Quality Improvement Project, we adapted the Alliance for Innovation on Maternal Health Severe Hypertension in Pregnancy bundle in a consortium of maternity hospitals in Ohio to improve care processes and outcomes for patients with a severe hypertensive event during pregnancy or the postpartum period. OBJECTIVE: This study aimed to report the first year of data from this Maternal Safety Quality Improvement Project, including an assessment of the process measures by hospital level of maternal care designation, and provide perspective on the unique challenges of implementing a large-scale Maternal Safety Quality Improvement Project during a global pandemic. STUDY DESIGN: This Maternal Safety Quality Improvement Project engaged Ohio level 1 to 4 maternity hospitals and provided multimodal quality improvement support. Participating hospitals submitted monthly patient-level data, which included all cases of new-onset sustained severe hypertension. The primary process measure was the proportion of birthing people in Ohio with sustained severe hypertension who received treatment with appropriate acute antihypertensive therapy within 60 minutes. The secondary process measures included receipt of a follow-up appointment after hospital discharge within 72 hours (if discharged on medication) or 10 days (if discharged without medication), a blood pressure cuff on hospital discharge, and education about urgent maternal warning signs. Data for primary and secondary process measures were plotted on a biweekly basis, and statistical process control methods were used to identify special cause variation over time. Data were stratified by various demographic variables, including race or ethnicity, insurance status, and maternal level of care. To assess the effect of the COVID-19 pandemic on this Maternal Safety Quality Improvement Project, process measure data were compared with COVID-19 case volume in Ohio across the study epoch. RESULTS: A total of 29 hospitals participated in the project from July 2020 to September 2021. Data were collected on 4948 hypertensive events representing 4678 unique patients. In aggregate, the primary process measure (timely and appropriate treatment) demonstrated a 19.3% increase (from a baseline of 56.5% to 67.4%; P<.001). The secondary process measures demonstrated significant increases ranging from 26.1% to 166.8% (all P<.001). Both non-Hispanic Black and White pregnant or postpartum people demonstrated shifts and sustained improvements in the treatment of severe hypertension, which did not differ by race across the study period. Process measure improvements were achieved and sustained across peaks in the COVID-19 pandemic. CONCLUSION: This Ohio Maternal Safety Quality Improvement Project demonstrated meaningful changes in project process measures in the identification and treatment of severe hypertension in pregnancy and the postpartum period. Process measures improvements were achieved across all hospital levels of maternal care, and differences were not observed by race or ethnicity. Our findings suggest that a robust and comprehensive quality improvement initiative with appropriate support and resources can achieve meaningful gains in the setting of a global pandemic.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Schneider P, Lorenz A, Menegay MC, et al. The Ohio Maternal Safety Quality Improvement Project: initial results of a statewide perinatal hypertension quality improvement initiative implemented during the COVID-19 pandemic. Am J Obstet Gynecol MFM. 2023. PMID: 37003568. doi:10.1016/j.ajogmf.2023.100912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。